Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer

Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer

Breast cancer is the second leading cause of cancer death among women. Human epidermal receptor 2 (HER2) positive breast cancer (HER2+ BC) is the most aggressive subtype of breast cancer, with poor prognosis and a high rate of recurrence. About one third of breast cancer is HER2+ BC with significant...

Full description

Bibliographic Details
Main Authors: Quanxia Lv, Ziyuan Meng, Yuanyuan Yu, Feng Jiang, Daogang Guan, Chao Liang, Junwei Zhou, Aiping Lu, Ge Zhang
Format: Article
Language:English
Published: MDPI AG 2016-12-01
Series:International Journal of Molecular Sciences
Subjects:
molecular mechanism
translational therapy
HER2 positive breast cancer
diagnostic tests
monoclonal antibodies
small molecular inhibitors
antibody–drug conjugates
Online Access:http://www.mdpi.com/1422-0067/17/12/2095

Internet

http://www.mdpi.com/1422-0067/17/12/2095

Similar Items